可定制的3D打印植入物含有triamcinolone乙化物:开发,分析,修改和药物释放的建模
Hanna Ponsar1,2, Julian Quodbach1,3
1Institute of Pharmaceutics and Biopharmaceutics, Heinrich Heine University, Universitaetsstr. 1, 40225 Duesseldorf, Germany.
Pharmaceutics
|August 26, 2023
概括
可定制的3D打印植入物提供量身定制的三氨酸 (TA) 输送,以改善亲肠治疗. 一个基于Higuchi的模型准确地预测了药物释放,简化了关节内疾病治疗的质量控制.
科学领域:
- 生物材料科学 生物材料科学
- 制药技术 制药技术 制药技术
- 药物输送系统 药物输送系统
背景情况:
- 目前的亲肠道疗法可以通过可定制的药物加载植入物来改进.
- 患者特定的需求需要适应剂量和药物释放配置文件.
研究的目的:
- 开发和评估一个模块化,3D打印的植入物,用于在三个月内提供个性化的三氨酸 (TA).
- 研究基于植入物架构的药物释放的修改和预测.
主要方法:
- 化沉积模型被用于打印具有可适应形状的外和药物载荷网络的两植入物.
- 纤维包括TA,乙纤维素,高素和三乙酸盐.
- 长期溶解研究和基于Higuchi的建模被用于分析释放性能和预测药物释放.
主要成果:
- 成功开发了具有对形状,剂量和药物释放的独立控制的模块化植入物.
- 在三个月的时间里,TA释放量从8.58±1.38毫克变化到21.93毫克±1.31毫克,受网络结构的影响.
- 基于Higuchi的方法在90天内使用初始的15天数据实现了良好的释放预测 (RMSEP ≤ 3.15%).
结论:
- 用3D打印的可定制植入物使得与三氨酸合物进行量身定制的腹腔治疗.
- 预测建模简化了质量控制,减少了植入物开发的分析工作.
- 优化植入物设计和释放预测对于有效的关节内疾病治疗至关重要.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Drug Release Characteristics
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.


